Verona Pharma

AI Score

0

Unlock

49.89
1.45 (2.99%)
At close: Jan 15, 2025, 12:32 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05
PE Ratio -28.98 -25.15 -7.15 -3.53 -1.36 -39.36 -36.17 -3.70K -1.05K -2.19K -836.21 -782.05 -988.7 -883.14 -870.35 -1.20K -507.97 -558.65 9.79K
PS Ratio n/a 3.77K 9.94 n/a 24.28K 357.12K 544.19 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
PB Ratio 6.32 7.50 2.69 1.24 1.29 12.45 9.28 538.39 1.40K 478.41 1.02K 756.11 419.79 484.43 310.51 412.47 214.06 87.14 260.07
P/FCF Ratio -31.38 -28.85 -11.95 -5.09 -1.28 -42.62 -35.45 -3.25K -1.20K -1.60K -976.44 -757.09 -1.06K -978.22 -846.01 -1.20K -505.89 -928.03 127.31K
P/OCF Ratio -31.38 -28.87 -11.95 -5.1 -1.29 -43.25 -35.82 -3.32K -1.23K -1.70K -1.03K -779.44 -1.08K -1.01K -859.07 -1.22K -513.03 -967.69 127.31K
OCF/S Ratio n/a -130.7 -0.83 n/a -18.86K -8.26K -15.19 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.21 0.05 0.04 0.03 0.03 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Quick Ratio 33.33 12.64 4.97 13.94 3.98 7.01 10.13 4.03 3.07 21.47 1.74 5.86 17.36 10.39 12.52 30.85 11.04 36.61 82.75
Current Ratio 33.33 12.77 5.09 14.26 4.26 7.01 10.13 4.03 3.07 21.47 1.74 5.86 16.78 10.06 11.19 30.04 9.51 36.61 82.58
Asset Turnover n/a 0.00 0.21 n/a 0.00 0.00 0.02 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Interest Coverage -32.85 -126.9 -215.63 -2.12K -243.09 n/a -407.62 -82.87 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Return on Equity (ROE) -0.22 -0.3 -0.38 -0.35 -0.94 -0.32 -0.26 -0.15 -1.33 -0.22 -1.22 -0.97 -0.42 -0.55 -0.36 -0.34 -0.42 -0.16 0.03
Return on Assets (ROA) -0.18 -0.26 -0.3 -0.32 -0.71 -0.27 -0.23 -0.11 -1 -0.21 -0.99 -0.9 -0.41 -0.52 -0.34 -0.34 -0.4 -0.15 0.03
Return on Capital (ROIC) -0.23 -0.27 -0.48 -0.39 -1.16 -0.4 -0.37 -0.2 -1.61 -0.3 -1.36 -0.99 -0.46 -0.55 -0.36 -0.37 -0.45 -0.17 -0.01
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a 24.45% 100.00% n/a -21.68K% 100.00% 100.00% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a -15.00K% -138.92% n/a -1.78M% -907.38K% -1.50K% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a -14.94K% -138.97% n/a -2.19M% -1.10M% -1.85K% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a -14.44K% -183.28% n/a -2.29M% -1.17M% -2.18K% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
FCF Margin n/a -13.08K% -83.17% n/a -1.90M% -837.99K% -1.54K% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a -14.69K% -105.47% n/a -1.37M% -916.21K% -1.61K% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a